Blood test uses AI to spot invisible cancer before surgery
NCT ID NCT07224737
Summary
This study tested a new blood test that uses artificial intelligence to detect hidden cancer spread that regular scans might miss in patients with a type of liver cancer called intrahepatic cholangiocarcinoma. Researchers analyzed tiny particles in the blood from 230 patients before their surgery to see if they could predict which patients had invisible cancer spread. The goal was to help doctors identify high-risk patients earlier so they could receive more appropriate treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91016, United States
Conditions
Explore the condition pages connected to this study.